Qing Sarah Yuan serves as Executive at Sigilon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Qing Sarah Yuan has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2023 involved selling 2,884 shares valued at $0.
Qing Sarah Yuan currently holds 2,884 shares of Sigilon Therapeutics, Inc. (SGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Qing Sarah Yuan has been a net neutral trader of SGTX stock. They have purchased $0 and sold $0 worth of shares.
Qing Sarah Yuan's most recent insider trade was on Aug 11, 2023, when they sold 2,884 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,884 |
| $19.24 |
| Discretionary |